Floatz logo

16.ALPHA.-FLUOROESTRADIOL

Invasive Lobular Breast Carcinoma

University of UtahSmall moleculePhase 2Dormant
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
30/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Invasive Lobular Breast Carcinoma cohort.

Asset / SponsorPhaseRating
FULVESTRANT
M.D. Anderson Cancer Center
Phase 3BB
Arimidex
Alliance for Clinical Trials in Oncology
Phase 3B
Entrectinib
Jules Bordet Institute
Phase 2CCC
TRASTUZUMAB
Auxilio Mutuo Cancer Center
Phase 2CCC
Epirubicin
Auxilio Mutuo Cancer Center
Phase 2CCC

View all 12 →

Same molecule, other indications

16.ALPHA.-FLUOROESTRADIOL is also rated in:

breast cancerDormant
B
Indicative ·
56 / 100
View asset →
estrogen-receptor positive breast cancerDormant
CCC
Indicative ·
49 / 100
View asset →
ductal breast carcinoma in situDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →